Skip to main content
. 2018 May 25;16(2):1000–1008. doi: 10.3892/etm.2018.6223

Figure 1.

Figure 1.

miR-302-3p is downregulated in cervical cancer. (A) Reverse transcription-quantitative polymerase chain reaction was utilized to evaluate the miR-302-3p expression level in cervical cancer tissues and adjacent normal tissues. (B) Low expression of miR-302-3p was associated with a shorter survival time in patients with cervical cancer. **P<0.01 vs. adjacent tissues.